Tea Life Co., Ltd. Cuts FY2026 Operating Profit Forecast 51.6%
Tea Life Co., Ltd. (TSE:3172) has revised down earnings and dividend guidance for the fiscal year ending July 2026, citing weakness in its wellness business and elevated costs from U.S. market expansion.
| Item | Before | After | Change |
|---|---|---|---|
| Revenue | JPY 12.0bn | JPY 11.1bn | -7.3% |
| Operating Profit | JPY 533M | JPY 258M | -51.6% |
| Ordinary Income | JPY 529M | JPY 271M | -48.8% |
| 親会社株主に帰属する当期純利益 | JPY 356M | JPY 188M | -47.2% |
| １株当たり当期純利益 | JPY 83M | JPY 44M | -47.3% |
The company attributed the downward revision to slowing teleshopping sales, contraction in the catalog retail market, and intensified e-commerce competition within its wellness segment. Rising raw material costs, shipping expenses, and third-party marketplace fees have compressed margins. Additionally, preliminary investments in the U.S. market have weighed on profitability, with subsidiary SENN INC. underperforming initial projections. The company recorded a JPY 35M impairment charge reflecting headwinds from U.S. tariff policy and Middle East geopolitical tensions. The logistics business remains stable but cannot offset wellness division losses.
Management views the impairment as a one-time charge and has maintained its year-end dividend (keijo rieki), signaling confidence in medium-term recovery. The revision reflects a strategic pivot toward operational restructuring and profitability improvement rather than aggressive expansion. International investors should monitor whether the wellness segment stabilizes in coming quarters and whether U.S. operations achieve profitability targets, as these will be critical to validating management’s recovery narrative.
Source: Original filing (TDnet) | 日本語版
This article is for informational purposes only and does not constitute investment advice. Always verify against the original filing.